A delayed endothelial-glial mechanism for CGRP-induced migraine
Abstract
CGRP is a key mediator in migraine and an important component of trigeminovascular signaling in primary headache disorders. Yet how CGRP induces delayed migraine-like pain after systemic infusion remains unresolved. Despite strong clinical and experimental evidence for its role, the mechanisms linking CGRP signaling to trigeminovascular nociception are still unclear. Based on a comprehensive review of the experimental literature, we propose a hypothesis, in which CGRP initiates a delayed signaling cascade that ultimately sensitizes trigeminal afferents. In this framework, CGRP promotes not only arterial vasodilatation but activates glial responses involving transcription-dependent processes and ion channel modulation that evolve over hours and provide a mechanistic explanation for the delayed onset of migraine-like pain. We further propose that peripheral endothelial-glial signaling may be amplified at ganglionic and spinal levels, contributing to trigeminovascular sensitization. In spontaneous migraine attacks, CGRP release appears as a consequence of primary afferent excitation through an excess of nitric oxide species activating transient receptor potential channels, most likely initiated by an endothelial dysfunction through metabolic disturbances including cortical spreading depression. These peripheral mechanisms do not exclude central changes that govern the periodic susceptibility of migraine and cluster headache attacks. Our model integrates existing observations…
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.